{"id":125540,"date":"2021-05-18T18:47:13","date_gmt":"2021-05-18T18:47:13","guid":{"rendered":"https:\/\/precoinnews.com\/?p=125540"},"modified":"2021-05-18T18:47:13","modified_gmt":"2021-05-18T18:47:13","slug":"covid-19-biggest-astrazeneca-jab-maker-unlikely-to-resume-major-exports-for-at-least-three-months-as-it-keeps-doses-for-india-surge","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/world-news\/covid-19-biggest-astrazeneca-jab-maker-unlikely-to-resume-major-exports-for-at-least-three-months-as-it-keeps-doses-for-india-surge\/","title":{"rendered":"COVID-19: Biggest AstraZeneca jab maker unlikely to resume major exports ‘for at least three months’ as it keeps doses for India surge"},"content":{"rendered":"
The world’s biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India’s coronavirus crisis.<\/p>\n
The Serum Institute of India (SII) said it hoped to restart exports to the Covax programme and other countries by the end of the year.<\/p>\n
Doses have been saved for India’<\/strong>s devastating COVID<\/strong> surge since exports were stopped a month ago.<\/p>\n Some 66 million doses from India have been sold or donated abroad so far – but the country has only vaccinated a tiny proportion of its huge population.<\/p>\n <\/p>\n Indian government sources said sizable exports were now unlikely to restart until at least October – a longer delay than expected.<\/p>\n SII had previously expected shipments to get back on track from June.<\/p>\n “It was internally discussed and some countries were asked not to expect export commitments given the current Indian situation,” one anonymous Indian government source told Reuters news agency.<\/p>\n It was not stated which countries could be affected.<\/p>\n India’s spike in cases has seen a chronic shortage of beds and oxygen, with many people having to source their own drugs and oxygen for relatives on the black market.<\/p>\n Despite being the world’s biggest vaccine producer, it has fully vaccinated only about 2.9% of its 1.35 billion population, according to health ministry data.<\/p>\n The SII said in a statement that it had never exported vaccines at the cost of the Indian people<\/p>\n <\/p>\n Other vaccine makers outside the country are being urged by the World Health Organisation to help fill the shortfall.<\/p>\n Its director-general, Tedros Ghebreyesus, has warned of “vaccine apartheid” – with wealthy nations surging ahead and poorer ones left struggling with too few doses.<\/p>\n The WHO’s Covax programme aims to provide several billion doses to poorer and less developed countries – with more than a billion of those expected from India.<\/p>\n Gavi, the vaccine alliance, said at least 140 million doses from SII that were lined up for Covax by the end of May would now stay in India.<\/p>\n UNICEF’s boss also urged G7 countries this week to increase donations to Covax to make up for the dip in supplies from India.<\/p>\n The organisation estimates a shortfall of some 190 million doses by the end of June.<\/p>\n US President Joe Biden said on Monday he would donate at least 20 million doses of the Pfizer, Moderna and Johnson & Johnson jabs – on top of 60 million AstraZeneca doses already promised.<\/p>\n <\/p>\n Meanwhile, India’s COVID spike is still far from over.<\/p>\n Deaths increased by a record 4,329 to nearly 279,000, according to figures released on Tuesday. And an average of 340,000 cases were confirmed each day last week.<\/p>\n However, there are signs of improvement in some areas – particularly the metropolis of Mumbai, where cases have fallen nearly 70% over the last week.<\/p>\n